Skip to content
  • Home
  • ABOUT
  • Medical & Affiliate Disclosure
BREAKING NEWS
1 Tablespoon Daily: What It Does (Dosing high-polyphenol extra virgin olive oil)  |  
Polyphenols Explained Simply  |  
Why “Smooth” Olive Oil Is Usually Weaker  |  
Grocery Store vs Real EVOO  |  
LIQUID MEDICINE: EVOO THAT ACTUALLY WORKS  |  

08/25/2026

  • Home
  • ABOUT
  • Medical & Affiliate Disclosure
Diabetes

FDA Issues CRL for Sotagliflozin in Type 1 Diabetes and CKD – HCPLive

Posted on 12/21/2024 by majac

The FDA issued a Complete Response Letter for sotagliflozin in type 1 diabetes with chronic kidney disease, citing risk-benefit concerns.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave

Post navigation

Previous: Grafton, MA Nutrition Consultations: Holistic Health & Wellness Plans Announced
Next: Positive Airway Pressure Devices Market Size, Share, Growth, Forecast, and Segments 2024
© 2026 | Theme NewsX Paper by wpthemespace.com